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ABSTRACT
There is an obvious need for a critical
discussion of the concepts ‘placebo’ and
‘placebo effect’. In a recent paper on the use
of placebos in clinical medicine, Gold and
Lichtenberg note the conceptual difﬁculties
but use the terminology in a confused way
throughout their paper. In our response, we
demonstrate these problems with a few
examples from their paper.
Gold and Lichtenberg provide an interest-
ing discussion about the use of placebos in
clinical medicine.
1 We agree with several of
their statements, for example, “We cannot
speak of placebo, or of any treatment for
that matter, divorced from its psychosocial
context” (p. 219). We also appreciate their
careful philosophical analysis on deception
and autonomy as related to the potential
clinical use of placebos.
The authors note the conceptual difﬁcul-
ties related to placebos and placebo effects,
and they redeﬁne the essential question
without using the term ‘placebo’: “when is
it ethical, in clinical practice, to offer a
therapeutic intervention, when the effect, if
any, of that intervention is expected to be
mediated by psychophysiological mechan-
isms, such as expectation, relaxation or con-
ditioned response” (p.220).
Unfortunately, however, the authors
ignore the conceptual difﬁculties and use
the terminology in a confused way through-
out their paper. Therefore, we wish to point
out a few examples of the problems they
have with their use of the term ‘placebo’:
The placebo is arguably the most com-
monly prescribed drug, across cultures
and throughout history. (p. 219)
Comment: This statement is grossly mis-
leading. Some treatments have been, and
still are, ineffective, but using an ineffective
treatment does not mean that the physician
is using a placebo. The term ‘placebo’
implies that the physician knows that the
treatment as such is ineffective but uses it
anyway. If we ﬁnd out that a standard treat-
ment was not effective after its use, labelling
the treatment a placebo is not justiﬁed.
Furthermore, claiming that placebos are
widely used presupposes the broad
umbrella concept ‘placebo’, which is
divided into ‘pure placebo’ and ‘impure
placebo’, as has been done in several recent
research papers.
2–4 The latter concept is
problematic and not at all helpful in under-
standing current or historical practices.
5
Physicians are reluctant to add even
potentially effective placebos to their
therapeutic arsenal. (p. 219)
Comment: Gold and Lichtenberg do
not describe what they mean with a
‘potentially effective placebo’. If there is
such a category, there should also logically
exist ‘potentially ineffective placebos’,
‘actually effective placebos’ and ‘actually
ineffective placebos’. Here the authors
forget the crucial importance of context,
although they emphasise it in the quota-
tion mentioned in our ﬁrst paragraph.
The 15–80% of physicians who use
placebo treatments … (p. 223)
Comment: Again, this statement presup-
poses the concept ‘impure placebo’,w h i c h
is a very vague category.
56For example,
according to the recent survey by Howick
et al,
2 97% of GPs had used ‘impure place-
bos’ in contrast to 12% of the GPs who had
used ‘pure placebos’ at least once during
their career. Only 1% of the respondents
reported using ‘pure placebos’ at least once
per week. Thus, the 15–80% mentioned by
Gold and Lichtenberg does not refer to the
use of ‘pure placebos’. According to ﬁgures
of Howick et al (deﬁned by “at least once in
their career”/“at least once per week”), it is
not possible to estimate the actual preva-
l e n c eo ft h eu s eo fp u r ep l a c e b o s( i e ,h o w
great a proportion of patients has received
‘impure’ or ‘pure placebos’). Furthermore,
there is no meaningful interpretation for the
result that 97% of the GPs reported using
‘impure placebos’ since the term covers a
large variety of treatments and other activ-
ities, from antibiotics for suspected viral
infections to vitamins without approved
indications and from positive suggestions to
unnecessary referrals.
25
Nevertheless, it is important to mention
that, according to an inﬂuential 2001
meta-analysis comparing placebo-treatment
arms with no treatment, placebos make no
clinical difference (ref. 20). (p. 220)
Comment: This statement is false. The
abstract of ref. 20 states: “In 27 trials
involving the treatment of pain, placebo
had a beneﬁcial effect (−0.27; 95% CI
−0.40 to −0.15).”
7 Such a particularly
narrow (far from null effect) 95% CI
implies very strong evidence of an effect
on pain in the placebo arms of the trial.
The physicians prescribe placebos …
(p. 219). Administration of placebos ...
(p. 223)
Comment: The authors do not describe
what they mean by such interventions in
practice. Do Gold and Lichtenberg propose
that (pure) placebos should be commer-
cially available or that physicians should
produce placebo tablets themselves to be
given to their own patients? If a physician
‘prescribes placebos’,w h a td o e sh eo rs h e
actually write in the prescription? We agree
that, at the ofﬁce, a physician can select
words so that he or she is not caught in a lie
or deception. However, what kind of pre-
scription will the patient have in his or her
hands when leaving the ofﬁce?
Furthermore, how will the physician
respond later if or when the patient ﬁnds
out that “I am prescribing a pill which
research suggests can be of beneﬁtt o
you…” (p. 221) actually means an inert
substance called placebo? Nowadays the
patient can rapidly search the internet to
ﬁnd out what the term ‘placebo’ means
even if the term was not familiar earlier.
If physicians start using inert substances to
increase the ‘placebo effect’,a n dt h e i r
patients learn about such a practice, the physi-
cians may lose trust, which is an essential part
of the doctor–patient relationship, as men-
tioned also by Gold and Lichtenberg
(p. 223). Keeping or losing trust does not
depend on a philosophical classiﬁcation of
the statement of the physician as a lie or
deception (p. 220). It is the patient who
decides whether he or she trusts the physician
irrespective of philosophers’ opinions outside
a particular doctor–patient relationship.
There is an obvious need for a critical dis-
cussion of the concepts ‘placebo’ and
‘placebo effect’.
8–11 The preceding examples
from the paper by Gold and Lichtenberg are
another demonstration of that need.
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